Nexiam 5 mg, 2,5 mg Sachets
PDF Leaflet Revision Date: 20 May 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of Gastro-Oesophageal Reflux Disease (GORD).
Dosage (summary)
2.5 mg to 10 mg once daily for infants; 20 mg to 40 mg once daily for adults.
Onset of Action / Duration
Onset: 1 hour, Duration: 13-17 hours.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety not established during pregnancy and lactation.
Key Drug Interactions
- Inhibits CYP2C19
- Increased digoxin absorption
- Increased warfarin INR
Contraindications
- Hypersensitivity to esomeprazole or benzimidazoles
Common side effects
- Headache
- Abdominal pain
- Diarrhoea
- Nausea/vomiting
Counselling Points
- Take with non-carbonated water.
- Monitor for gastrointestinal symptoms.
- Report any allergic reactions.
Serious warnings
- May mask gastric malignancy symptoms
- Increased risk of gastrointestinal infections
Important Disclaimer
The Nexiam 5 mg, 2,5 mg Sachets professional information leaflet below is the property of Astrazeneca Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
